BioSpace News Archive

Neurelis, Inc., announced today the commercial availability of VALTO for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity.

BioPharma has today decided to donate its World Health Organization (WHO) approved facility for coronavirus COVID-19 vaccine research and treatments.

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced U.S. Food and Drug Administration (FDA) clearance of its Basal-IQ™ technology as an interoperable automated glycemic controller (iAGC).

Rite Aid Corporation announced that the executive leadership team will host an Analyst Day on Monday, March 16, 2020 in New York, NY.

The world’s most innovative medical aesthetic leaders will join together on March 26-29th at the Four Seasons Beverly Hills to share the latest discoveries, trends, and techniques shaping the industry

Syndigo, a leading provider of verified product content syndication services, today announced the addition of Unique Device Identifier (UDI) compliant product information for medical device manufacturers, enabling syndication to healthcare systems providers through its Content Experience Hub (CXH) platform

MDsave, the world’s first online marketplace providing patients the ability to shop, compare and instantly purchase their healthcare services, today announced the appointment of Greg Born as company president and chief operating officer

Jisc, the UK’s research and education not-for-profit that negotiates licences and digital content agreements on behalf of UK universities, and Wiley, a global leader in research and education, have struck a four year “read and publish” agreement that offers researchers at UK universities the means to publish open access in all Wiley journals at no direct cost to them.

Funding will help combat blood disorders, heart disease, diabetes and vision loss

Recro, Inc. (NASDAQ:REPH) a leading contract development and manufacturing organization (CDMO) with integrated solutions for the development, formulation, regulatory support, manufacturing and packaging of oral solid dose drug products, today announced that it will report year end 2019 financial results on Wednesday, March 4, 2020.